[144] Amprius Technologies, Inc. SEC Filing

Rhea-AI Filing Summary

AMPX reported proposed sales of Common Stock under registered plans. The filing lists 62,500 shares associated with restricted stock vesting on 06/07/2025 and 104,132 shares from an exercise of options on 03/10/2026, each described as "under a registered plan" and shown as sales by the issuer.

Insights

Securities Compliance Counsel

Routine Form 144 listing of securities to be sold under registered plans.

The filing lists two entries: 62,500 shares tied to restricted stock vesting on 06/07/2025 and 104,132 shares from option exercise on 03/10/2026, both described as "under a registered plan."

These entries align with standard Rule 144 notification practice; the form records intended resale mechanics and timing indicated by the dates but does not state actual sale execution details or proceeds.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	166632	2985428.90	137019004	03/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/07/2025	Restricted stock vesting under a registered plan	Issuer			62500	06/07/2025	Not Applicable
Common	03/10/2026	Exercise of options under a registered plan	Issuer			104132	03/10/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does AMPX's Form 144 filing indicate?

It indicates proposed resales of Common Stock under registered plans, listing 62,500 shares tied to vesting on 06/07/2025 and 104,132 shares from an option exercise on 03/10/2026. The form records intent, not confirmed sales.

Are the shares in AMPX's filing already sold?

No. The form lists securities "to be sold" with specific dates: vesting on 06/07/2025 and exercise on 03/10/2026

Who is the seller in the AMPX Form 144 entries?

The entries are described as transactions "Issuer" under registered plans, referencing restricted stock vesting and option exercise. The form shows the issuer-related plan as the source; it does not name an individual seller or disclose net proceeds recipients.

Do AMPX's Form 144 entries disclose sale proceeds or methods?

No. The excerpt shows the number of shares and dates but does not disclose aggregate proceeds or detailed distribution methods. The entries note "Cash" for the exercise row, but specific proceeds or sale mechanics are not provided in the excerpt.